Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Cholesterol

Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial

H. Risstad; J. A. Kristinsson; M. W. Fagerland; C. W. le Roux; K. I. Birkeland; H. L. Gulseth; P. M. Thorsby; R. P. Vincent; M. Engström; T. Olbers; T. Mala Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial Surg Obes Relat Dis
Cholesterol

Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial

H. Risstad; T. T. Søvik; M. Engström; E. T. Aasheim; M. W. Fagerland; M. F. Olsén; J. A. Kristinsson; C. W. le Roux; T. Bøhmer; K. I. Birkeland; T. Mala; T. Olbers Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial JAMA Surg
Cholesterol Insulin Resistance & Diabetes Metabolic Syndrome

Detailed Description of Change in Serum Cholesterol Profile with Incremental Weight Loss After Restrictive Bariatric Surgery

G. J. Ooi; A. Earnest; L. Doyle; C. Laurie; J. M. Wentworth; K. Sikaris; C. W. le Roux; P. R. Burton; P. E. O’Brien; W. A. Brown Detailed Description of Change in Serum Cholesterol Profile with Incremental Weight Loss After Restrictive Bariatric Surgery Obesity Surgery
Cholesterol Metabolic Syndrome

Changes in glycaemic control, blood pressure and lipids 5 years following laparoscopic adjustable gastric banding combined with medical care in patients with type 2 diabetes: a longitudinal analysis

P. Mistry; V. Currie; P. Super; C. W. le Roux; A. A. Tahrani; R. Singhal Changes in glycaemic control, blood pressure and lipids 5 years following laparoscopic adjustable gastric banding combined with medical care in patients with type 2 diabetes: a longitudinal analysis Clin Obes
Cholesterol Insulin Resistance & Diabetes Metabolic Syndrome

The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids

M. A. Glaysher; J. Ward; M. Aldhwayan; A. Ruban; C. G. Prechtl; H. L. Fisk; N. Chhina; W. Al-Najim; C. Smith; N. Klimowska-Nassar; N. Johnson; E. Falaschetti; A. P. Goldstone; A. D. Miras; J. P. Byrne; P. C. Calder; J. P. Teare The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids Clin Nutr
Cholesterol

Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents

P. M. Ryan; E. Patterson; R. M. Kent; H. Stack; P. M. O'Connor; K. Murphy; V. L. Peterson; R. Mandal; D. S. Wishart; T. G. Dinan; J. F. Cryan; R. J. Seeley; C. Stanton; R. P. Ross Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents Sci Rep
Cholesterol

Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice

N. M. Pathak; P. J. B. Millar; V. Pathak; P. R. Flatt; V. A. Gault Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice Mol Cell Endocrinol
Cholesterol Insulin Resistance & Diabetes

Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice

V. Parthsarathy; C. Hogg; P. R. Flatt; F. P. M. O'Harte Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice Diabetes Obes Metab
Cholesterol Insulin Resistance & Diabetes

Sodium salicylate rewires hepatic metabolic pathways in obesity and attenuates IL-1β secretion from adipose tissue: The implications for obesity-impaired reverse cholesterol transport

S. Kajani; S. Curley; M. E. O'Reilly; X. Yin; E. T. Dillon; W. Guo; K. N. Nilaweera; L. Brennan; H. M. Roche; F. C. McGillicuddy Sodium salicylate rewires hepatic metabolic pathways in obesity and attenuates IL-1β secretion from adipose tissue: The implications for obesity-impaired reverse cholesterol transport Mol Metab
Cholesterol

Newer posts

← Previous Page1 … Page4 Page5

Search for:

Recent Posts

Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update
ECO2023 Teaching Workshops – Registration Open!

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI